Evidence-based medicine: The time has come to set standards for staging

Journal of Pathology

Volumn 221, Issue 4, 2010, Pages 357-360

  Quirke, Phil ^a,b   Cuvelier, Claude ^c   Ensari, Arzu ^d,e,f   Glimelius, Bengt ^g,h   Laurberg, Søren ⁱ   Ortiz, Hector ^j   Piard, Francoise ^k   Punt, Cornelis J A ^l   Glenthoj, Anders ^m   Pennickx, Freddy ⁿ   Seymour, Matt ^o   Valentini, Vincenzo ^p   Williams, Geraint ^q,r   Nagtegaal, Iris D ^l  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b NHS Bowel Cancer Screening Pathology Committee ^*  (United Kingdom)

^c GHENT UNIVERSITY   (Belgium)

^d ANKARA UNIVERSITY   (Turkey)

^e Turkish Gastrointestinal Pathology Working Group   (Turkey)

^f European Society of Pathology Digestive Diseases Working Party   (Turkey)

^g UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^h Swedish Rectal Cancer Group   (Sweden)

ⁱ AARHUS UNIVERSITY HOSPITAL   (Denmark)

^j PUBLIC UNIVERSITY OF NAVARRE   (Spain)

^k DIJON UNIVERSITY HOSPITAL   (France)

^l RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^m BISPEBJERG HOSPITAL   (Denmark)

ⁿ Belgian Cancer Registry   (Belgium)

^o ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^p FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^q CARDIFF UNIVERSITY   (United Kingdom)

^r Royal College of Pathologists Colorectal Cancer Guidelines

more..

Author keywords

Colorectal cancer; Evidence based medicine; Lymph nodes; Staging; TNM; Tumour deposits

Indexed keywords

CANCER INVASION; CANCER STAGING; CELL MIGRATION; CLINICAL DECISION MAKING; COLORECTAL CANCER; EVALUATION; EVIDENCE BASED MEDICINE; PATIENT CARE; PRIORITY JOURNAL; PROGNOSIS; REPRODUCIBILITY; SHORT SURVEY; TUMOR CLASSIFICATION; TUMOR DIFFERENTIATION;

COLORECTAL NEOPLASMS; EVIDENCE-BASED MEDICINE; HUMANS; LYMPHATIC METASTASIS; NEOPLASM STAGING; NEOPLASMS;

EID: 77955487866     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2720     Document Type: Short Survey

References (13)

1. Quirke P, Williams GT, Ectors N, et al . The future of the TNM staging system in colorectal cancer: time for a debate? Lancet Oncol 2007; 8: 651-657. (Pubitemid 46995637)
2. Valentini V, Aristei C, Glimelius B, et al . Multidisciplinary rectal cancer management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2). Radiother Oncol 2009; 92: 148-163.
3. Sobin LH, Wittekind C. TNMClassification of Malignant Tumours, 6th edn. Wiley: New York, 2002.
4. Greene FL, Page D, Fleming ID, et al (eds). AJCC Staging Handbook, 6th edn. Springer: New York, 2002.
5. Howarth SM, Morgan JM, Williams GT. The new (6th edition) TNM classification of colorectal cancer - a stage too far. Gut 2006;53(suppl 3): A21.
6. Wunsch K, Muller J, Jahnig H, et al . Shape is not associated with the origin of pericolonic tumor deposits. Am J Clin Pathol 2010;133: 388-394.
7. Sobin LH, Wittekind C. TNMClassification of Malignant Tumours, 5th edn. Wiley: New York, 1997.
8. Fleming ID, Cooper JS, Henson DE, et al (eds). AJCC Cancer Staging Manual, 5th edn. Lippincott Raven: Philadelphia, PA, 1997.
9. Sobin LH. TNM, 6th edition: new developments in general concepts and rules. Semin Surg Oncol 2003; 21: 19-22.
10. Sobin LH, Gospodarowicz MK, Wittekind C. TNM Classification of Malignant Tumours, 7th edn. Wiley-Blackwell: New York, 2009.
11. Edge SB, Byrd DR, Carducci MA, et al (eds). AJCC Cancer Staging Manual, 7th edn. Springer: New York, 2009.
12. Nagtegaal ID, Quirke P. Colorectal tumour deposits in the mesorectum and pericolon; a critical review. Histopathology 2007;51: 141-149. (Pubitemid 47083979)
13. http://www.foxtrot.bham.ac.uk/FOxTROT-Protocol-v4.pdf.